Praxis Precision Medicines, Inc. PRAX Return on equity

Return on equity at other companies

Jazz PharmaceuticalsJAZZ

-9.1%-21.2pp

Xenon PharmaceuticalsXENE

-43.6%+8.2pp

Stoke Therapeutics, Inc.STOK

-45.6%-66.1pp

Rapport Therapeutics, Inc.RAPP

-40%+22.3pp

Neurocrine BiosciencesNBIX

22.5%+10.1pp

BiogenBIIB

4.8%-4.3pp

FAQ

What is Praxis Precision Medicines, Inc.'s return on equity?

Praxis Precision Medicines, Inc. (PRAX) reported return on equity of -38.9% in Q2 2026.

How has Praxis Precision Medicines, Inc.'s return on equity changed year-over-year?

Praxis Precision Medicines, Inc.'s return on equity increased by 36.3% year-over-year, from -61% to -38.9%.

What is the long-term trend for Praxis Precision Medicines, Inc.'s return on equity?

Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s return on equity has grown at a -7.3% compound annual growth rate (CAGR), from -62.1% to -45.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.